Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 15/03/20041 min de leitura
Determination of Regulatory Review Period for Purposes of Patent Extension; FACTIVE
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) has determined the regulatory review period for FACTIVE and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of three applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of three patents that claim that human drug product.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →